Clearbridge Investments, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Clearbridge Investments, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $15,654 - $16,447	-108 Reduced 0.01%	830,668 $126 Million
Q2 2022 Aug 11, 2022	SELL	$83.14 - $145.99 $26.7 Million - $46.9 Million	-321,053 Reduced 27.87%	830,776 $121 Million
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $30.7 Million - $39.9 Million	279,259 Added 32.0%	1,151,829 $137 Million
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $79,185 - $117,893	794 Added 0.09%	872,570 $120 Million
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $250,881 - $352,553	-2,538 Reduced 0.29%	871,776 $121 Million
Q2 2021 Aug 13, 2021	BUY	$65.78 - $105.02 $7.69 Million - $12.3 Million	116,974 Added 15.45%	874,314 $84.9 Million
Q1 2021 May 13, 2021	BUY	$64.07 - $91.75 $14.3 Million - $20.5 Million	223,709 Added 41.92%	757,340 $51.8 Million
Q4 2020 Feb 10, 2021	BUY	$65.07 - $98.24 $10.7 Million - $16.2 Million	164,475 Added 44.55%	533,631 $45.7 Million
Q3 2020 Nov 12, 2020	BUY	$59.04 - $77.95 $5.3 Million - $7 Million	89,811 Added 32.15%	369,156 $24 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $8.1 Million - $20.7 Million	279,345 New	279,345 $20.4 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.